Brian Swierenga

Articles by Brian Swierenga

  • API Roundtable

    Monday, August 05, 2013
    Active Pharmaceutical Ingredient manufacturers have faced their share of regulatory concerns over the years. In fact, the adoption of the ICH Q7A API GMP Guidance would have never occurred if not for the absence of an accepted API GMP globally. In...
  • <<
  • >>